Suppr超能文献

术后阿片类药物处方与新的持续性阿片类药物使用:过度处方的风险。

Postoperative Opioid Prescribing and New Persistent Opioid Use: The Risk of Excessive Prescribing.

机构信息

Department of Surgery, Michigan Medicine, Ann Arbor, MI.

Center for Healthcare Outcomes and Policy, Michigan Medicine, Ann Arbor, MI.

出版信息

Ann Surg. 2023 Jun 1;277(6):e1225-e1231. doi: 10.1097/SLA.0000000000005392. Epub 2022 Jan 21.

Abstract

OBJECTIVE

Evaluate the association between postoperative opioid prescribing and new persistent opioid use.

SUMMARY BACKGROUND DATA

Opioid-nave patients who develop new persistent opioid use after surgery are at increased risk of opioid-related morbidity and mortality. However, the extent to which postoperative opioid prescribing is associated with persistent postoperative opioid use is unclear.

METHODS

Retrospective study of opioid-naïve adults undergoing surgery in Michigan from 1/1/2017 to 10/31/2019. Postoperative opioid prescriptions were identified using a statewide clinical registry and prescription fills were identified using Michigan's prescription drug monitoring program. The primary outcome was new persistent opioid use, defined as filling at least 1 opioid prescription between post-discharge days 4 to 90 and filling at least 1 opioid prescription between post-discharge days 91 to 180.

RESULTS

A total of 37,654 patients underwent surgery with a mean age of 52.2 (16.7) years and 20,923 (55.6%) female patients. A total of 31,920 (84.8%) patients were prescribed opioids at discharge. Six hundred twenty-two (1.7%) patients developed new persistent opioid use after surgery. Being prescribed an opioid at discharge was not associated with new persistent opioid use [adjusted odds ratio (aOR) 0.88 (95% confidence interval (CI) 0.71-1.09)]. However, among patients prescribed an opioid, patients prescribed the second largest [12 (interquartile range (IQR) 3) pills] and largest [20 (IQR 7) pills] quartiles of prescription size had higher odds of new persistent opioid use compared to patients prescribed the smallest quartile [7 (IQR 1) pills] of prescription size [aOR 1.39 (95% CI 1.04-1.86) andaOR 1.97 (95% CI 1.442.70), respectively].

CONCLUSIONS

In a cohort of opioid-naïve patients undergoing common surgical procedures, the risk of new persistent opioid use increased with the size of the prescription. This suggests that while opioid prescriptions in and of themselves may not place patients at risk of long-term opioid use, excessive prescribing does. Consequently, these findings support ongoing efforts to mitigate excessive opioid prescribing after surgery to reduce opioid-related harms.

摘要

目的

评估术后开具阿片类药物处方与新出现持续性阿片类药物使用之间的关联。

背景资料概要

术后新出现持续性阿片类药物使用者为阿片类药物相关发病率和死亡率增加的高危人群。然而,术后开具阿片类药物处方与持续性术后阿片类药物使用之间的关联程度尚不清楚。

方法

这是一项在密歇根州于 2017 年 1 月 1 日至 2019 年 10 月 31 日期间接受手术的阿片类药物初治成年人的回顾性研究。使用全州临床注册中心确定术后阿片类药物处方,使用密歇根州的处方药物监测计划确定处方用药情况。主要结局为新出现持续性阿片类药物使用,定义为出院后第 4 至 90 天内至少开具 1 份阿片类药物处方,以及出院后第 91 至 180 天内至少开具 1 份阿片类药物处方。

结果

共有 37654 名患者接受了手术,平均年龄为 52.2(16.7)岁,20923 名(55.6%)为女性。共有 31920 名(84.8%)患者在出院时开具了阿片类药物处方。622 名(1.7%)患者术后出现新出现持续性阿片类药物使用。出院时开具阿片类药物处方与新出现持续性阿片类药物使用无关[调整后比值比(aOR)0.88(95%置信区间(CI)0.71-1.09)]。然而,在开具阿片类药物处方的患者中,与开具最小处方剂量[7(IQR 1)片]的患者相比,开具第二大[12(IQR 3)片]和最大[20(IQR 7)片]剂量的患者新出现持续性阿片类药物使用的几率更高[aOR 1.39(95% CI 1.04-1.86)和 aOR 1.97(95% CI 1.44-2.70)]。

结论

在接受常见手术的阿片类药物初治患者队列中,新出现持续性阿片类药物使用的风险随处方剂量的增加而增加。这表明,尽管阿片类药物处方本身可能不会使患者面临长期使用阿片类药物的风险,但过度处方确实会增加这种风险。因此,这些发现支持持续努力减轻术后阿片类药物过度处方,以减少阿片类药物相关危害。

相似文献

引用本文的文献

本文引用的文献

2
The Association of Postoperative Opioid Prescriptions with Patient Outcomes.术后阿片类药物处方与患者结局的关联。
Ann Surg. 2022 Dec 1;276(6):e1076-e1082. doi: 10.1097/SLA.0000000000004965. Epub 2021 Jun 4.
6
New Persistent Opioid Use After Inguinal Hernia Repair.腹股沟疝修补术后新的持续性阿片类药物使用。
Ann Surg. 2022 Nov 1;276(5):e577-e583. doi: 10.1097/SLA.0000000000004560. Epub 2020 Oct 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验